Easy Access and Express Report Delivery Service
Gastrointestinal Drugs Market, Global Outlook and Forecast 2024-2030
Report ID
46964
Publisher
Market Monitor Global
Published Date
07-Feb
Delivery Format
PDF
No of Report Page
115
Editor's Rating
-
Report Details
This research report provides a comprehensive analysis of the Gastrointestinal Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Gastrointestinal Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Gastrointestinal Drugs, challenges faced by the industry, and potential opportunities for market players. The global Gastrointestinal Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Gastrointestinal Drugs market presents opportunities for various stakeholders, including Chronic Gastritis, Functional Dyspepsia. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Gastrointestinal Drugs market. Additionally, the growing consumer demand present avenues for market expansion. The global Gastrointestinal Drugs market was valued at US$ 32740 million in 2023 and is projected to reach US$ 41410 million by 2030, at a CAGR of 3.4% during the forecast period. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Key Features: The research report on the Gastrointestinal Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders. Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Gastrointestinal Drugs market. Market Overview: The report provides a comprehensive overview of the Gastrointestinal Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Prescription Gastrointestinal Drug, OTC Gastrointestinal Drug), region, and application, highlighting the key drivers, challenges, and opportunities within each segment. Market Dynamics: The report analyses the market dynamics driving the growth and development of the Gastrointestinal Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Gastrointestinal Drugs market's trajectory. Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Gastrointestinal Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. Market Segmentation and Forecast: The report segment the Gastrointestinal Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions. Technological Trends: The report should highlight the key technological trends shaping the Gastrointestinal Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences. Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Gastrointestinal Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders. Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Gastrointestinal Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments. Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Gastrointestinal Drugs market. Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts. Market Segmentation Gastrointestinal Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. Market segment by Type Prescription Gastrointestinal Drug OTC Gastrointestinal Drug Market segment by Application Chronic Gastritis Functional Dyspepsia Peptic Ulcer Acute Gastroenteritis Other Global Gastrointestinal Drugs Market Segment Percentages, By Region and Country, 2023 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Major players covered AstraZeneca Sanofi Bayer Pfizer GlaxoSmithKline Teva Zeria (Tillotts) Perrigo Boehringer Ingelheim Purdue Pharma C.B. Fleet Abbott Jiangzhong Xian-Janssen Outline of Major Chapters: Chapter 1: Introduces the definition of Gastrointestinal Drugs, market overview. Chapter 2: Global Gastrointestinal Drugs market size in revenue and volume. Chapter 3: Detailed analysis of Gastrointestinal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Gastrointestinal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Global Gastrointestinal Drugs capacity by region & country. Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 11: The main points and conclusions of the report. -
Table Of Content
1 Introduction to Research & Analysis Reports 1.1 Gastrointestinal Drugs Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Gastrointestinal Drugs Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Gastrointestinal Drugs Overall Market Size 2.1 Global Gastrointestinal Drugs Market Size: 2023 VS 2030 2.2 Global Gastrointestinal Drugs Revenue, Prospects & Forecasts: 2019-2030 2.3 Global Gastrointestinal Drugs Sales: 2019-2030 3 Company Landscape 3.1 Top Gastrointestinal Drugs Players in Global Market 3.2 Top Global Gastrointestinal Drugs Companies Ranked by Revenue 3.3 Global Gastrointestinal Drugs Revenue by Companies 3.4 Global Gastrointestinal Drugs Sales by Companies 3.5 Global Gastrointestinal Drugs Price by Manufacturer (2019-2024) 3.6 Top 3 and Top 5 Gastrointestinal Drugs Companies in Global Market, by Revenue in 2023 3.7 Global Manufacturers Gastrointestinal Drugs Product Type 3.8 Tier 1, Tier 2 and Tier 3 Gastrointestinal Drugs Players in Global Market 3.8.1 List of Global Tier 1 Gastrointestinal Drugs Companies 3.8.2 List of Global Tier 2 and Tier 3 Gastrointestinal Drugs Companies 4 Sights by Product 4.1 Overview 4.1.1 By Type - Global Gastrointestinal Drugs Market Size Markets, 2023 & 2030 4.1.2 Prescription Gastrointestinal Drug 4.1.3 OTC Gastrointestinal Drug 4.2 By Type - Global Gastrointestinal Drugs Revenue & Forecasts 4.2.1 By Type - Global Gastrointestinal Drugs Revenue, 2019-2024 4.2.2 By Type - Global Gastrointestinal Drugs Revenue, 2025-2030 4.2.3 By Type - Global Gastrointestinal Drugs Revenue Market Share, 2019-2030 4.3 By Type - Global Gastrointestinal Drugs Sales & Forecasts 4.3.1 By Type - Global Gastrointestinal Drugs Sales, 2019-2024 4.3.2 By Type - Global Gastrointestinal Drugs Sales, 2025-2030 4.3.3 By Type - Global Gastrointestinal Drugs Sales Market Share, 2019-2030 4.4 By Type - Global Gastrointestinal Drugs Price (Manufacturers Selling Prices), 2019-2030 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Gastrointestinal Drugs Market Size, 2023 & 2030 5.1.2 Chronic Gastritis 5.1.3 Functional Dyspepsia 5.1.4 Peptic Ulcer 5.1.5 Acute Gastroenteritis 5.1.6 Other 5.2 By Application - Global Gastrointestinal Drugs Revenue & Forecasts 5.2.1 By Application - Global Gastrointestinal Drugs Revenue, 2019-2024 5.2.2 By Application - Global Gastrointestinal Drugs Revenue, 2025-2030 5.2.3 By Application - Global Gastrointestinal Drugs Revenue Market Share, 2019-2030 5.3 By Application - Global Gastrointestinal Drugs Sales & Forecasts 5.3.1 By Application - Global Gastrointestinal Drugs Sales, 2019-2024 5.3.2 By Application - Global Gastrointestinal Drugs Sales, 2025-2030 5.3.3 By Application - Global Gastrointestinal Drugs Sales Market Share, 2019-2030 5.4 By Application - Global Gastrointestinal Drugs Price (Manufacturers Selling Prices), 2019-2030 6 Sights by Region 6.1 By Region - Global Gastrointestinal Drugs Market Size, 2023 & 2030 6.2 By Region - Global Gastrointestinal Drugs Revenue & Forecasts 6.2.1 By Region - Global Gastrointestinal Drugs Revenue, 2019-2024 6.2.2 By Region - Global Gastrointestinal Drugs Revenue, 2025-2030 6.2.3 By Region - Global Gastrointestinal Drugs Revenue Market Share, 2019-2030 6.3 By Region - Global Gastrointestinal Drugs Sales & Forecasts 6.3.1 By Region - Global Gastrointestinal Drugs Sales, 2019-2024 6.3.2 By Region - Global Gastrointestinal Drugs Sales, 2025-2030 6.3.3 By Region - Global Gastrointestinal Drugs Sales Market Share, 2019-2030 6.4 North America 6.4.1 By Country - North America Gastrointestinal Drugs Revenue, 2019-2030 6.4.2 By Country - North America Gastrointestinal Drugs Sales, 2019-2030 6.4.3 US Gastrointestinal Drugs Market Size, 2019-2030 6.4.4 Canada Gastrointestinal Drugs Market Size, 2019-2030 6.4.5 Mexico Gastrointestinal Drugs Market Size, 2019-2030 6.5 Europe 6.5.1 By Country - Europe Gastrointestinal Drugs Revenue, 2019-2030 6.5.2 By Country - Europe Gastrointestinal Drugs Sales, 2019-2030 6.5.3 Germany Gastrointestinal Drugs Market Size, 2019-2030 6.5.4 France Gastrointestinal Drugs Market Size, 2019-2030 6.5.5 U.K. Gastrointestinal Drugs Market Size, 2019-2030 6.5.6 Italy Gastrointestinal Drugs Market Size, 2019-2030 6.5.7 Russia Gastrointestinal Drugs Market Size, 2019-2030 6.5.8 Nordic Countries Gastrointestinal Drugs Market Size, 2019-2030 6.5.9 Benelux Gastrointestinal Drugs Market Size, 2019-2030 6.6 Asia 6.6.1 By Region - Asia Gastrointestinal Drugs Revenue, 2019-2030 6.6.2 By Region - Asia Gastrointestinal Drugs Sales, 2019-2030 6.6.3 China Gastrointestinal Drugs Market Size, 2019-2030 6.6.4 Japan Gastrointestinal Drugs Market Size, 2019-2030 6.6.5 South Korea Gastrointestinal Drugs Market Size, 2019-2030 6.6.6 Southeast Asia Gastrointestinal Drugs Market Size, 2019-2030 6.6.7 India Gastrointestinal Drugs Market Size, 2019-2030 6.7 South America 6.7.1 By Country - South America Gastrointestinal Drugs Revenue, 2019-2030 6.7.2 By Country - South America Gastrointestinal Drugs Sales, 2019-2030 6.7.3 Brazil Gastrointestinal Drugs Market Size, 2019-2030 6.7.4 Argentina Gastrointestinal Drugs Market Size, 2019-2030 6.8 Middle East & Africa 6.8.1 By Country - Middle East & Africa Gastrointestinal Drugs Revenue, 2019-2030 6.8.2 By Country - Middle East & Africa Gastrointestinal Drugs Sales, 2019-2030 6.8.3 Turkey Gastrointestinal Drugs Market Size, 2019-2030 6.8.4 Israel Gastrointestinal Drugs Market Size, 2019-2030 6.8.5 Saudi Arabia Gastrointestinal Drugs Market Size, 2019-2030 6.8.6 UAE Gastrointestinal Drugs Market Size, 2019-2030 7 Manufacturers & Brands Profiles 7.1 AstraZeneca 7.1.1 AstraZeneca Company Summary 7.1.2 AstraZeneca Business Overview 7.1.3 AstraZeneca Gastrointestinal Drugs Major Product Offerings 7.1.4 AstraZeneca Gastrointestinal Drugs Sales and Revenue in Global (2019-2024) 7.1.5 AstraZeneca Key News & Latest Developments 7.2 Sanofi 7.2.1 Sanofi Company Summary 7.2.2 Sanofi Business Overview 7.2.3 Sanofi Gastrointestinal Drugs Major Product Offerings 7.2.4 Sanofi Gastrointestinal Drugs Sales and Revenue in Global (2019-2024) 7.2.5 Sanofi Key News & Latest Developments 7.3 Bayer 7.3.1 Bayer Company Summary 7.3.2 Bayer Business Overview 7.3.3 Bayer Gastrointestinal Drugs Major Product Offerings 7.3.4 Bayer Gastrointestinal Drugs Sales and Revenue in Global (2019-2024) 7.3.5 Bayer Key News & Latest Developments 7.4 Pfizer 7.4.1 Pfizer Company Summary 7.4.2 Pfizer Business Overview 7.4.3 Pfizer Gastrointestinal Drugs Major Product Offerings 7.4.4 Pfizer Gastrointestinal Drugs Sales and Revenue in Global (2019-2024) 7.4.5 Pfizer Key News & Latest Developments 7.5 GlaxoSmithKline 7.5.1 GlaxoSmithKline Company Summary 7.5.2 GlaxoSmithKline Business Overview 7.5.3 GlaxoSmithKline Gastrointestinal Drugs Major Product Offerings 7.5.4 GlaxoSmithKline Gastrointestinal Drugs Sales and Revenue in Global (2019-2024) 7.5.5 GlaxoSmithKline Key News & Latest Developments 7.6 Teva 7.6.1 Teva Company Summary 7.6.2 Teva Business Overview 7.6.3 Teva Gastrointestinal Drugs Major Product Offerings 7.6.4 Teva Gastrointestinal Drugs Sales and Revenue in Global (2019-2024) 7.6.5 Teva Key News & Latest Developments 7.7 Zeria (Tillotts) 7.7.1 Zeria (Tillotts) Company Summary 7.7.2 Zeria (Tillotts) Business Overview 7.7.3 Zeria (Tillotts) Gastrointestinal Drugs Major Product Offerings 7.7.4 Zeria (Tillotts) Gastrointestinal Drugs Sales and Revenue in Global (2019-2024) 7.7.5 Zeria (Tillotts) Key News & Latest Developments 7.8 Perrigo 7.8.1 Perrigo Company Summary 7.8.2 Perrigo Business Overview 7.8.3 Perrigo Gastrointestinal Drugs Major Product Offerings 7.8.4 Perrigo Gastrointestinal Drugs Sales and Revenue in Global (2019-2024) 7.8.5 Perrigo Key News & Latest Developments 7.9 Boehringer Ingelheim 7.9.1 Boehringer Ingelheim Company Summary 7.9.2 Boehringer Ingelheim Business Overview 7.9.3 Boehringer Ingelheim Gastrointestinal Drugs Major Product Offerings 7.9.4 Boehringer Ingelheim Gastrointestinal Drugs Sales and Revenue in Global (2019-2024) 7.9.5 Boehringer Ingelheim Key News & Latest Developments 7.10 Purdue Pharma 7.10.1 Purdue Pharma Company Summary 7.10.2 Purdue Pharma Business Overview 7.10.3 Purdue Pharma Gastrointestinal Drugs Major Product Offerings 7.10.4 Purdue Pharma Gastrointestinal Drugs Sales and Revenue in Global (2019-2024) 7.10.5 Purdue Pharma Key News & Latest Developments 7.11 C.B. Fleet 7.11.1 C.B. Fleet Company Summary 7.11.2 C.B. Fleet Business Overview 7.11.3 C.B. Fleet Gastrointestinal Drugs Major Product Offerings 7.11.4 C.B. Fleet Gastrointestinal Drugs Sales and Revenue in Global (2019-2024) 7.11.5 C.B. Fleet Key News & Latest Developments 7.12 Abbott 7.12.1 Abbott Company Summary 7.12.2 Abbott Business Overview 7.12.3 Abbott Gastrointestinal Drugs Major Product Offerings 7.12.4 Abbott Gastrointestinal Drugs Sales and Revenue in Global (2019-2024) 7.12.5 Abbott Key News & Latest Developments 7.13 Jiangzhong 7.13.1 Jiangzhong Company Summary 7.13.2 Jiangzhong Business Overview 7.13.3 Jiangzhong Gastrointestinal Drugs Major Product Offerings 7.13.4 Jiangzhong Gastrointestinal Drugs Sales and Revenue in Global (2019-2024) 7.13.5 Jiangzhong Key News & Latest Developments 7.14 Xian-Janssen 7.14.1 Xian-Janssen Company Summary 7.14.2 Xian-Janssen Business Overview 7.14.3 Xian-Janssen Gastrointestinal Drugs Major Product Offerings 7.14.4 Xian-Janssen Gastrointestinal Drugs Sales and Revenue in Global (2019-2024) 7.14.5 Xian-Janssen Key News & Latest Developments 8 Global Gastrointestinal Drugs Production Capacity, Analysis 8.1 Global Gastrointestinal Drugs Production Capacity, 2019-2030 8.2 Gastrointestinal Drugs Production Capacity of Key Manufacturers in Global Market 8.3 Global Gastrointestinal Drugs Production by Region 9 Key Market Trends, Opportunity, Drivers and Restraints 9.1 Market Opportunities & Trends 9.2 Market Drivers 9.3 Market Restraints 10 Gastrointestinal Drugs Supply Chain Analysis 10.1 Gastrointestinal Drugs Industry Value Chain 10.2 Gastrointestinal Drugs Upstream Market 10.3 Gastrointestinal Drugs Downstream and Clients 10.4 Marketing Channels Analysis 10.4.1 Marketing Channels 10.4.2 Gastrointestinal Drugs Distributors and Sales Agents in Global 11 Conclusion 12 Appendix 12.1 Note 12.2 Examples of Clients 12.3 Disclaimer -
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
